Therapeutic use of the OKT3 anti-T cell monoclonal antibody: mode of action and side effects

Transplant Proc. 1988 Oct;20(5 Suppl 6):79-83.
No abstract available

MeSH terms

  • Animals
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Graft Rejection / drug effects*
  • Humans
  • Kidney Transplantation
  • Muromonab-CD3
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Monoclonal
  • Muromonab-CD3